会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • Tetracyclic spiro-hydantoin aldose reductase inhibitors
    • 四环素螺 - 乙内酰脲 - 醛糖 - 抑制素 - 抑制素。
    • EP0173497A1
    • 1986-03-05
    • EP85305636.4
    • 1985-08-08
    • PFIZER INC.
    • Schnur, Rodney Caughren
    • C07D471/20A61K31/495
    • C07D471/10C07C51/16C07C59/185C07C59/88C07D213/55C07C59/58
    • Novel biologically-active tetracyclic spirohydantoin derivatives of formula

      wherein

      X is hydrogen, fluorine, chlorine or methyl; and R is hydrogen, alkyl, alkenyl, cycloalkyl, benzy, 4-hydroxy- benzy!, pyridyl, HSCH 2 -, CH 3 SCH 2 -, CH 3 SCH 2 CH 2 -, FCH 2 -, HOCH 2 -, CH 2 CH(OH)-, CH 3 CH(OH)CH 2 -, HOOCCH 2 -, HOOCCH 2 CH 2 -, H 2 NCOCH 2 -, H 2 NCOCH 2 CH 2 -, H 2 NCH 2 CH 2 -

      COOC 2 H 5 , -CONH 2 , CONH(CH 2 ) 2 0H, -CONH cyclohexyl, -CONH-Bu, -CONH(CH 2 ) 3 N(CH 3 ) 2 , -CON(C 2 H 5 ) 2 ,
      phenyl or phenyl substituted by chlorine, fluorine, bromine, hydroxy, methyl, methoxy, trifluoromethyl, -COCH 3 , -N(CH 3 ) 2 , -SCH 3 , -SOCH 3 , -SO 2 CH 3 , -COOH, -CONH 2 , -COOCH 3 or -CON Alk, are disclosed.

      These derivatives are potent inhibitors of aldose reductase and useful in treating diabetic complications are disclosed.
      Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed.
    • 新型生物活性四环螺乙内酰脲衍生物,其结构式如下:其中X为氢,氟,氯或甲基; 4-羟基苄基,吡啶基,HSCH2-,CH3SCH2-,CH3SCH2CH2-,FCH2 - ,HOCH2-,CH2CH(OH) - ,CH3CH(OH)CH2-,HOOCCH2- ,HOOCCH 2 CH 2 - ,H 2 NCOCH 2 - ,H 2 NHCOCH 2 CH 2 - ,H 2 NHCH 2 CH 2 -CH 2 CH 2 - ,... H 2 H 2 CH 2 CH 2 - ,... CH 2 COCO 2 H 5,-CONH 2,CONH(CH 2)2 OH,-CONH环己基,-CONH-nBu ,-CONH(CH 2)3 N(CH 3)2,-CON(C 2 H 5)2,... CH或苯基或被氯,氟,溴,羟基,甲基,甲氧基,三氟甲基,-COCH 3,-N( CH 3)2,-SCH 3,-SOCH 3,-SO 2 CH 3,-COOH,-CONH 2,-COOCH 3或-CON Alk。 ...这些衍生物是醛糖还原酶的有效抑制剂,并且可用于治疗糖尿病并发症。 还公开了含有新化合物的药物组合物和治疗慢性糖尿病并发症的方法。